These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 4650868)

  • 1. Some observations on the blood levels of phenylalanine in dilute mice and a comparison between human phenylketonuria and the disease of mice homozygous for the dilute lethal gene.
    Seller MJ
    Clin Genet; 1972; 3(6):495-500. PubMed ID: 4650868
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolism of phenylalanine in mice homozygous for the gene 'dilute lethal'.
    Woolf LI; Jakubovic A; Woolf F; Bory P
    Biochem J; 1970 Oct; 119(5):895-903. PubMed ID: 5531182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Free amino acid pool in the brain of mice homozygous for the gene "dilute lethal".
    Simler S; Essayag S; Ledig M; Koehl C; Mandel P
    J Neurosci Res; 1977; 3(4):281-7. PubMed ID: 566796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of heterozygotes for phenylketonuria. Total body phenylalanine clearance and concentrations of phenylalanine and tyrosine in the plasms of fasting subjects compared.
    Jagenburg R; Regårdh CG; Rödjer S
    Clin Chem; 1977 Sep; 23(9):1654-60. PubMed ID: 890909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical phenylketonuria in a seven-year-old profoundly retarded girl: development of phenylalanine tolerance, in spite of apparently continued failure to convert phenylalanine to tyrosine.
    Cohn GH; Ouellette EM; Moser HW; Efron ML
    Neurology; 1968 Mar; 18(3):310-1. PubMed ID: 5690427
    [No Abstract]   [Full Text] [Related]  

  • 6. Phenylalanine loading and aromatic acid excretion in normal subjects and heterozygotes for phenylketonuria.
    Blau K; Summer GK; Newsome HC; Edwards CH
    Clin Chim Acta; 1973 May; 45(3):197-205. PubMed ID: 4708049
    [No Abstract]   [Full Text] [Related]  

  • 7. Epilepsy in phenylketonuria: a complex dependence on serum phenylalanine levels.
    Martynyuk AE; Ucar DA; Yang DD; Norman WM; Carney PR; Dennis DM; Laipis PJ
    Epilepsia; 2007 Jun; 48(6):1143-50. PubMed ID: 17484755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Phenylalanine tolerance and results of oral phenylalanine load in children with phenylketonuria in various ages].
    Bührdel P; Theile H
    Kinderarztl Prax; 1975 Nov; 43(11):501-8. PubMed ID: 1214334
    [No Abstract]   [Full Text] [Related]  

  • 9. [Phenylalanine concentration in the cerebrospinal fluid and blood, both entering and leaving the brain, of phenylketonuria patients].
    Bulakhova LA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(10):1542-6. PubMed ID: 4775335
    [No Abstract]   [Full Text] [Related]  

  • 10. Phenylalanine metabolites in phenylketonuria.
    Clemens PC; Schünemann MH; Kohlschütter A; Hoffman GF
    J Pediatr; 1990 Apr; 116(4):665-6. PubMed ID: 2319411
    [No Abstract]   [Full Text] [Related]  

  • 11. Intracellular concentrations of phenylalanine, tyrosine and alpha-aminobutyric acid in 13 homozygotes and 19 heterozygotes for phenylketonuria (PKU) compared with 26 normals.
    Thalhammer O; Pollak A; Lubec G; Königshofer H
    Hum Genet; 1980; 54(2):213-6. PubMed ID: 7390492
    [No Abstract]   [Full Text] [Related]  

  • 12. Treated phenylketonuria: intelligence and blood phenylalanine levels.
    Fuller R; Shuman J
    Am J Ment Defic; 1971 Mar; 75(5):539-45. PubMed ID: 5551499
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of two different methods for measurement of phenylalanine in dried blood spots.
    Rivero A; Allué JA; Grijalba A; Palacios M; Merlo SG
    Clin Chem Lab Med; 2000 Aug; 38(8):773-6. PubMed ID: 11071072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluctuations in phenylalanine concentrations in phenylketonuria: a review of possible relationships with outcomes.
    Cleary M; Trefz F; Muntau AC; Feillet F; van Spronsen FJ; Burlina A; Bélanger-Quintana A; Giżewska M; Gasteyger C; Bettiol E; Blau N; MacDonald A
    Mol Genet Metab; 2013 Dec; 110(4):418-23. PubMed ID: 24090706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of the phenylalanine tolerance test in detection of heterozygote carriers of phenylketonuria gene].
    Bernat K
    Pol Tyg Lek; 1992 Mar 2-9; 47(9-10):219-21. PubMed ID: 1437822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Man made disease: clinical manifestations of low phenylalanine levels in an inadequately treated phenylketonuria patient and mouse study.
    Pode-Shakked B; Shemer-Meiri L; Harmelin A; Stettner N; Brenner O; Abraham S; Schwartz G; Anikster Y
    Mol Genet Metab; 2013; 110 Suppl():S66-70. PubMed ID: 24206931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal screening for phenylketonuria. II. Age dependence of initial phenylalanine in infants with PKU.
    Holtzman NA; Mellits ED; Kallman CH
    Pediatrics; 1974 Mar; 53(3):353-7. PubMed ID: 4815254
    [No Abstract]   [Full Text] [Related]  

  • 18. Optimal serum phenylalanine for adult patients with phenylketonuria (PKU).
    Hanley WB
    Mol Genet Metab; 2013 Nov; 110(3):199-200. PubMed ID: 24090705
    [No Abstract]   [Full Text] [Related]  

  • 19. Phenylalanine hydroxylase in dilute lethal mice.
    Treiman DM; Tourian A
    Biochim Biophys Acta; 1973 Jun; 313(1):163-9. PubMed ID: 4745673
    [No Abstract]   [Full Text] [Related]  

  • 20. Concentration of phenylalanine in the blood serum of patients with various degrees of phenylketonuria.
    Blyumina MG; Sitnichenko EI
    Sov Genet; 1971 Apr; 7(4):527-31. PubMed ID: 5163392
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.